Similar Papers

Paper Title
Journal
Date
Author
SMURF1 activates the cGAS/STING/IFN-1 signal axis by mediating YY1 ubiquitination to accelerate the progression of lupus nephritis
Xiaoyan Li ... Xiaojie He
Autoimmunity | VOL. 56
Xiaoyan Li, et. al.Xiaoyan Li ... Xiaojie He
22 Nov 2023
Fasudil compensates podocyte injury via CaMK4/Rho GTPases signal and actin cytoskeleton-dependent activation of YAP in MRL/lpr mice
Fengyuan Tian ... Yongsheng Fan
International Immunopharmacology | VOL. 119
Fengyuan Tian, et. al.Fengyuan Tian ... Yongsheng Fan
01 Jun 2023
Fra-2 is a novel candidate drug target expressed in the podocytes of lupus nephritis
Changliang Xu ... Furong Li
Clinical Immunology | VOL. 197
Changliang Xu, et. al.Changliang Xu ... Furong Li
05 Oct 2018
Advanced oxidation protein products induce apoptosis in podocytes through induction of endoplasmic reticulum stress.
Guang Rong ... Na Duan
Journal of Physiology and Biochemistry | VOL. 71
Guang Rong, et. al.Guang Rong ... Na Duan
22 Jul 2015
View more papers

More From: Lupus Science & Medicine

Paper Title
Journal
Date
Author
Postmarketing safety evaluation of belimumab: a pharmacovigilance analysis
Huqun Li ... Cuilian Guo
Lupus Science & Medicine | VOL. 12
Huqun Li, et. al.Huqun Li ... Cuilian Guo
09 Jan 2025
Interplay of NF-κB and PPAR-γ transcription factors in patients with juvenile systemic lupus erythematosus
Sinem Durmus ... Ozgur Kasapcopur
Lupus Science & Medicine | VOL. 12
Sinem Durmus, et. al.Sinem Durmus ... Ozgur Kasapcopur
08 Jan 2025
Racial differences in clinical trial perceptions among a large, predominantly Black cohort of people with systemic lupus erythematosus in the Southeastern USA
Jessica Nicole Williams ... Sung Sam Lim
Lupus Science & Medicine | VOL. 12
Jessica Nicole Williams, et. al.Jessica Nicole Williams ... Sung Sam Lim
01 Jan 2025
Belimumab versus telitacicept in sequential treatment after rituximab for refractory lupus nephritis: a real-world multicentre study
Yiting Chen ... Fei Han
Lupus Science & Medicine | VOL. 12
Yiting Chen, et. al.Yiting Chen ... Fei Han
01 Jan 2025
View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.